Resources

Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C

Showing 1 to 10 of 185 resources

  • Good practice case study: Pharmacy in Ramsgate giving out daily treatment
    This good practice case study looks at the service developed in a collaboration between Courts Pharmacy in Ramsgate, a nurse from East Kent Hospitals University NHS Foundation Trust, and The Forward Trust. Patients who are deemed unlikely to independently manage four weeks of treatment are given the medication in the pharmacy itself so they do not have to look after large numbers of tablets for long periods of time, getting around current legislative barriers preventing the dispensing of hepatitis C treatment from pharmacies.
    UK, England, South East Case study PDF
  • Summary report: Hepatitis C good practice roadshow, West London - September 2019
    This report provides a summary of the good practice hepatitis C roadshow held by HCV Action and Public Health England with the West London ODN on 27th September 2019. The report includes summaries of the workshops held on the day and attendees' reflections and pledges for action.
    UK, England, Greater London 22 Oct 2019 Training, Reports & Research PDF
  • HCV Action and Public Health England hepatitis C good practice roadshow, West London: Presentations
    On 27th September 2019, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow with the West London ODN. The event featured presentations on progress in tackling hepatitis C, nationally and locally, and examples of best practice in the prevention, diagnosis, testing and treatment of hepatitis C.
    UK, England, Greater London 07 Oct 2019 Training, Strategy & Planning PDF
  • Public Health England Hepatitis C in the UK 2019 Report
    Public Health England published its annual 'Hepatitis C in the UK' report on 13th September 2019. This is the key national reporting document for hepatitis C and monitors the UK's progress towards its goal of eliminating the virus by 2030. This year's report finds that although fewer people are living with chronic hepatitis C than in previous years, the proportion of these people who do not know they are infected has increased to two-thirds (up from half).
    UK Reports & Research, Strategy & Planning PDF
  • PHE Infectious Diseases Strategy front page
    Public Health England's Infectious Diseases Strategy 2020-25
    Public Health England published 'PHE Infectious Diseases Strategy 2020-25: Addressing urgent threats in the 21st century' in September 2019. The strategy sets out PHE's 10 priorities for infectious diseases over the next five years and how they will achieve these. Of particular relevance to hepatitis C is priority 4, which aims to "Eliminate hepatitis B and C, Tuberculosis and HIV and halt the rise in sexually transmitted infections in our population". The document states PHE will "enable work on detection, surveillance and control of HIV, hepatitis B, C, and TB".
    UK, England Reports & Research PDF
  • screen grab of first page of case study
    Good practice case study: Treatment support for people experiencing homelessness
    This good practice case study looks at the work of homelessness charity Harbour Housing, based in Cornwall. Since last year, Harbour Housing has had a dedicated bed to support people experiencing homelessness who are also infected with hepatitis C. They collaborated with NHS England and Addaction to develop an exclusive care pathway and to make treatment as easy and accessible as possible. So far, they have got seven people successfully treated hepatitis C.
    UK, England, South West 04 Sep 2019 Case study PDF
  • Hepatitis C: interventions for patient case-finding and linkage to care
    Published in July 2019 this review summarizes the evidence for interventions to increase case-finding and linkage to care for hepatitis C-infected patients, in order to support commissioning and provision of evidence-based interventions as part of efforts to achieve hepatitis C (HCV) elimination as a major public health threat in the UK.
    UK, England, Northern Ireland, Scotland, Wales 30 Jul 2019 Reports & Research PDF
  • Legal Barriers for Providing HCV Community Testing in Europe
    This report from the Correlation European Harm Reduction Network is based on a telephone survey conducted in September and October 2018 with representatives of harm reduction services and NGOs that offer low-threshold services to drug users.
    UK, Rest of World Reports & Research PDF
  • EMCDDA on models of care for hepatitis C in drugs services
    The European Monitoring Centre for Drugs and Drug Addiction published 'Hepatitis C: new models of care for drugs services' in July 2019. This aims to highlight the importance of targeting people who inject drugs as a key population for the elimination of hepatitis C in Europe and to show innovative practice in the form of 11 case studies (three of which are from England). The report provides key insights into the results, impact, sustainability and transferability of each practice to guide the implementation of these new models of care in other countries and settings.
    UK, Rest of World, England, Greater London 29 Jul 2019 Reports & Research, Strategy & Planning PDF
  • Drug-related infectious diseases in Europe
    This report from the European Monitoring Centre for Drugs and Drug Addiction provides an overview of infectious disease surveillance data, outbreak investigations, and prevention and control measures among people who inject drugs in Europe up to February 2019, including viral hepatitis.
    UK, Rest of World 16 Jul 2019 Reports & Research PDF

Pages